180
Views
0
CrossRef citations to date
0
Altmetric
CASE SERIES

Veno-Arterial Extracorporeal Membrane Oxygenation in the Treatment of Hemodynamically Unstable Lupus Myocarditis: A Retrospective Case Series Study

, , , , &
Pages 3761-3768 | Published online: 04 Jul 2022

References

  • Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14(9):683–686. doi:10.1191/0961203305lu2200oa
  • Thomas G, Cohen Aubart F, Chiche L, et al. Lupus myocarditis: initial presentation and long term outcomes in a multicentric series of 29 patients. J Rheumatol. 2017;44(1):24–32. doi:10.3899/jrheum.160493
  • Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J. 1985;110(6):1257–1265. doi:10.1016/0002-8703(85)90023-7
  • Guglin M, Zucker MJ, Bazan VM, et al. Venoarterial ECMO for adults: JACC scientific expert panel. J Am Coll Cardiol. 2019;73(6):698–716. doi:10.1016/j.jacc.2018.11.038
  • Barnado A, Kamen DL. Myocarditis successfully treated with intravenous immunoglobulin in a patient with systemic lupus erythematous and myositis. Am J Med Sci. 2014;347(3):256–257. doi:10.1097/MAJ.0000000000000232
  • Borenstein DG, Fye WB, Arnett FC, Stevens MB. The myocarditis of systemic lupus erythematosus: association with myositis. Ann Intern Med. 1978;89(5 Pt 1):619–624. doi:10.7326/0003-4819-89-5-619
  • Falcão CA, Lucena N, Alves IC, Pessoa AL, Godoi ET. Lupus carditis. Arq Bras Cardiol. 2000;74(1):55–71. doi:10.1590/S0066-782X2000000100007
  • Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000;343(19):1388–1398. doi:10.1056/NEJM200011093431908
  • Mavrogeni S, Bratis C, Iakovou I, Kolovou G. Systemic lupus erythematosus: two sides of the same coin evaluated by cardiovascular magnetic resonance imaging. Lupus. 2011;20(12):1338–1339. doi:10.1177/0961203311411351
  • Cooper LT. Myocarditis. N Engl J Med. 2009;360(15):1526–1538. doi:10.1056/NEJMra0800028
  • Aringer M, Costenbader K, Daikh D, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151–1159. doi:10.1136/annrheumdis-2018-214819
  • Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–2121. doi:10.1056/NEJMra1100359
  • Zhang L, Zhu YL, Li MT, et al. Lupus myocarditis: a case-control study from China. Chin Med J. 2015;128(19):2588–2594. doi:10.4103/0366-6999.166029
  • Chan YK, Li EK, Tam LS, Chow LT, Ng HK. Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol. 2003;32(5):306–308. doi:10.1080/03009740310003956
  • Martorell EA, Hong C, Rust DW, et al. A 32-year-old woman with arthralgias and severe hypotension. Arthritis Rheum. 2008;59(11):1670–1675. doi:10.1002/art.24195
  • Chan TM, Li FK, Tang CS, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. Hong Kong-Guangzhou Nephrology Study Group. N Engl J Med. 2000;343(16):1156–1162. doi:10.1056/NEJM200010193431604
  • Naarendorp M, Kerr LD, Khan AS, Ornstein MH. Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of 6 cases. J Rheumatol. 1999;26(10):2257–2260.
  • Moder KG, Amin S, Mazlumzadeh M, Crowson C, Ytterberg S. The effect of mycophenolate mofetil on patients with active non-renal SLE. Clin Exp Rheumatol. 2007;25(6):932.
  • Law WG, Thong BY, Lian TY, Kong KO, Chng HH. Acute lupus myocarditis: clinical features and outcome of an oriental case series. Lupus. 2005;14(10):827–831. doi:10.1191/0961203305lu2228oa